Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Philip

Showing results (251-260 of 441) with videos related to

Pageof 45
Sort By:
Blood|October 1, 1993
Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factorJ Y Blay, N Burdin, F Rousset, et al.
Pediatrie|January 1, 1992
[Retinoblastoma]E Bouffet, D Frappaz, J D Grange, et al.
International Journal of Cancer|October 15, 1981
EBV-positive Burkitt's lymphoma from Algeria, with a three-way rearrangement involving chromosomes 2, 8 and 9T Philip, G M Lenoir, J Fraisse, et al.
Bulletin Du Cancer|January 26, 1999
[Standards, options and recommendations (SOR) for clinical care of rhabdomyosarcoma (RMS) and other soft tissue sarcoma in children. Federation of the French Cancer Centers. French Society of Pediatric Oncology]D Sommelet, R Pinkerton, M Brunat-Mentigny, et al.
Biochemistry|October 19, 2019
Designed Helical Peptides as Functional Probes for γ-SecretaseAnijamol T Philip, Sujan Devkota, Shweta Malvankar, et al.
AJNR. American Journal of Neuroradiology|January 14, 2022
Rates of Epidural Blood Patch following Lumbar Puncture Comparing Atraumatic versus Bevel-Tip Needles Stratified for Body Mass IndexJ T Philip, M A Flores, R D Beegle, et al.
Cancer Research|August 1, 1989
Correspondence re: John R. Yanelli et al., Enhancement of Human Lymphokine-activated Killer Cell Cytolysis and a Method for Increasing Lymphokine-activated Killer Cell Yields to Cancer Patients. Cancer Res., 48: 5696-5700, 1988M C Favrot, C Coze, V Combaret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1992
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2P A Palmer, J Vinke, T Philip, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastomaV Combaret, N Gross, C Lasset, et al.
Bulletin Du Cancer|January 1, 1995
[CD44 expression: a new prognostic factor in neuroblastoma]V Combaret, C Lasset, R Bouvier, et al.
Pageof 45

Showing results (251-260 of 441) with videos related to

Sort By:
Pageof 45
Blood|October 1, 1993
Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factorJ Y Blay, N Burdin, F Rousset, et al.
Pediatrie|January 1, 1992
[Retinoblastoma]E Bouffet, D Frappaz, J D Grange, et al.
International Journal of Cancer|October 15, 1981
EBV-positive Burkitt's lymphoma from Algeria, with a three-way rearrangement involving chromosomes 2, 8 and 9T Philip, G M Lenoir, J Fraisse, et al.
Bulletin Du Cancer|January 26, 1999
[Standards, options and recommendations (SOR) for clinical care of rhabdomyosarcoma (RMS) and other soft tissue sarcoma in children. Federation of the French Cancer Centers. French Society of Pediatric Oncology]D Sommelet, R Pinkerton, M Brunat-Mentigny, et al.
Biochemistry|October 19, 2019
Designed Helical Peptides as Functional Probes for γ-SecretaseAnijamol T Philip, Sujan Devkota, Shweta Malvankar, et al.
AJNR. American Journal of Neuroradiology|January 14, 2022
Rates of Epidural Blood Patch following Lumbar Puncture Comparing Atraumatic versus Bevel-Tip Needles Stratified for Body Mass IndexJ T Philip, M A Flores, R D Beegle, et al.
Cancer Research|August 1, 1989
Correspondence re: John R. Yanelli et al., Enhancement of Human Lymphokine-activated Killer Cell Cytolysis and a Method for Increasing Lymphokine-activated Killer Cell Yields to Cancer Patients. Cancer Res., 48: 5696-5700, 1988M C Favrot, C Coze, V Combaret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1992
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2P A Palmer, J Vinke, T Philip, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastomaV Combaret, N Gross, C Lasset, et al.
Bulletin Du Cancer|January 1, 1995
[CD44 expression: a new prognostic factor in neuroblastoma]V Combaret, C Lasset, R Bouvier, et al.
Pageof 45